|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1932666265 |
| 003 |
DE-627 |
| 005 |
20260106101911.0 |
| 007 |
tu |
| 008 |
250806s2025 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1932666265
|
| 035 |
|
|
|a (DE-599)KXP1932666265
|
| 035 |
|
|
|a (OCoLC)1530785799
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|b ger
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
4 |
|a 610
|a 570
|q DE-101
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 32
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Soosten, Laura von
|d 1989-
|e VerfasserIn
|0 (DE-588)1374547719
|0 (DE-627)1934206970
|4 aut
|
| 245 |
1 |
0 |
|a Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma
|c presented by M. Sc. Laura von Soosten ; referees: Prof. Dr. Martin Müller, Prof. Dr. med. Stefan M. Pfister
|
| 264 |
|
1 |
|a Heidelberg
|c [2025]
|
| 264 |
|
4 |
|c © 2025
|
| 300 |
|
|
|a XII, 162 Seiten
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-University Heidelberg
|d 2025
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in englischer und deutscher Sprache
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|c 20260106
|f FID
|f DE-2298
|x XA-DE-NI
|z FID Pharmazie
|2 pdager
|5 DE-84
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Müller, Martin
|e AkademischeR BetreuerIn
|0 (DE-588)1099920175
|0 (DE-627)858790890
|0 (DE-576)469375639
|4 dgs
|
| 700 |
1 |
|
|a Pfister, Stefan
|d 1974-
|e AkademischeR BetreuerIn
|0 (DE-588)123850215
|0 (DE-627)706450930
|0 (DE-576)293908400
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20250908
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2025
|
| 998 |
|
|
|g 1374547719
|a Soosten, Laura von
|m 1374547719:Soosten, Laura von
|d 140000
|d 140001
|e 140000PS1374547719
|e 140001PS1374547719
|k 0/140000/
|k 1/140000/140001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1932666265
|e 4770242883
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"name":{"displayForm":["presented by M. Sc. Laura von Soosten ; referees: Prof. Dr. Martin Müller, Prof. Dr. med. Stefan M. Pfister"]},"recId":"1932666265","origin":[{"dateIssuedDisp":"[2025]","publisherPlace":"Heidelberg","dateIssuedKey":"2025"}],"noteThesis":["Dissertation. - Ruprecht-Karls-University Heidelberg. - 2025"],"id":{"eki":["1932666265"]},"corporate":[{"roleDisplay":"Grad-verleihende Institution","display":"Universität Heidelberg","role":"dgg"}],"type":{"bibl":"thesis"},"physDesc":[{"extent":"XII, 162 Seiten","noteIll":"Illustrationen, Diagramme"}],"person":[{"roleDisplay":"VerfasserIn","given":"Laura von","display":"Soosten, Laura von","role":"aut","family":"Soosten"},{"family":"Müller","role":"dgs","display":"Müller, Martin","given":"Martin","roleDisplay":"AkademischeR BetreuerIn"},{"display":"Pfister, Stefan","given":"Stefan","roleDisplay":"AkademischeR BetreuerIn","family":"Pfister","role":"dgs"}],"title":[{"title_sort":"Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma","title":"Establishing experimental therapeutic modalities and CRISPR/Cas9 screening platforms to interrogate vulnerabilities in pediatric high-grade glioma"}],"language":["eng"]}
|
| SRT |
|
|
|a SOOSTENLAUESTABLISHI2025
|
